Centerpoint Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-10
| Closed | -$8K | – | 565 |
|
|
2023
Q3 | $8K | Hold |
10
| – | – | ﹤0.01% | 351 |
|
|
2023
Q2 | $7K | Hold |
10
| – | – | ﹤0.01% | 372 |
|
|
2023
Q1 | $8K | Buy |
10
+2
| +25% | +$1.6K | ﹤0.01% | 367 |
|
|
2022
Q4 | $6K | Hold |
8
| – | – | ﹤0.01% | 344 |
|
|
2022
Q3 | $6K | Hold |
8
| – | – | ﹤0.01% | 255 |
|
|
2022
Q2 | $5K | Hold |
8
| – | – | ﹤0.01% | 275 |
|
|
2022
Q1 | $6K | Hold |
8
| – | – | ﹤0.01% | 266 |
|
|
2021
Q4 | $5K | Buy |
+8
| New | +$5K | ﹤0.01% | 273 |
|
|
2020
Q3 | – | Sell |
-24
| Closed | -$15K | – | 268 |
|
|
2020
Q2 | $15K | Buy |
+24
| New | +$15K | 0.01% | 138 |
|
|
2019
Q1 | – | Sell |
-55
| Closed | -$21K | – | 263 |
|
|
2018
Q4 | $21K | Hold |
55
| – | – | 0.02% | 127 |
|
|
2018
Q3 | $22K | Hold |
55
| – | – | 0.02% | 130 |
|
|
2018
Q2 | $19K | Hold |
55
| – | – | 0.02% | 146 |
|
|
2018
Q1 | $19K | Hold |
55
| – | – | 0.02% | 136 |
|
|
2017
Q4 | $21K | Buy |
+55
| New | +$21K | 0.02% | 115 |
|